M 755 (Fexofenadine 180 mg)
Pill imprint M 755 has been identified as Fexofenadine hydrochloride 180 mg.
Fexofenadine is used in the treatment of urticaria; allergic rhinitis and belongs to the drug class antihistamines. Risk cannot be ruled out during pregnancy. Fexofenadine 180 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M 755
- 180 mg
- 18.00 mm
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- butylated hydroxyanisole
FD&C Blue No. 1
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0526||UDL Laboratories Inc|
|67544-1090||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
More about fexofenadine
- Fexofenadine orally disintegrating tablets
- Fexofenadine suspension
- Fexofenadine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.